Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04353960 · ClinicalTrials.gov registry record

The Alaska Oculocardiac Reflex Study

A clinical trial of Bradycardia and Strabismus, sponsored by Alaska Blind Child Discovery.

Recruiting
Registry status
4,000
Enrollment target
1
Study location

NCT04353960 is a study of Bradycardia and Strabismus that is actively recruiting participants, run by Alaska Blind Child Discovery. The registered enrollment target is 4,000 participants, roughly in line with the 4,275-participant average among 29 other Bradycardia trials with a reported enrollment target. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04353960, a study of Bradycardia and Strabismus, is actively recruiting participants, sponsored by Alaska Blind Child Discovery.

RECRUITING
Registry status
4,000 participants
Enrollment target
1
Study location

Study Summary

Observation study monitoring vital signs and anesthetic variables particularly heart rate during prospective, ocular manipulation and specifically uniform tension on extra ocular muscles during strabismus surgery. \*IRB approval from 1992 covered in letter from then IRB chair Dr. Judith Whitcomb, Anchorage, Alaska (letter 10/2020).\*

Conditions Studied

Interventions

  • DIAGNOSTIC_TEST electrocardiograph

Study Locations (1)

Alaska

  • Alaska Children's EYE & Strabismus - Anchorage

Trial Details

FieldValue
Enrollment Target 4,000 participants
Start Date 1992-09-01
Est. Completion 2035-12-31

Sponsor

Alaska Blind Child Discovery

7 total trials

What the Registry Record Tells You About NCT04353960

The ClinicalTrials.gov registry entry for NCT04353960 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 4,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 4,275-participant average among 29 other Bradycardia trials with a reported enrollment target. The listed sponsor is Alaska Blind Child Discovery, which has 7 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Bradycardia appearing as the primary indexed condition, and to 1 intervention - of which electrocardiograph is the first listed.

NCT04353960 reports 1 study location spanning 1 distinct geographic area - top geographies include Alaska.

Frequently Asked Questions

What is clinical trial NCT04353960 about?

NCT04353960 is a clinical study titled "The Alaska Oculocardiac Reflex Study". Observation study monitoring vital signs and anesthetic variables particularly heart rate during prospective, ocular manipulation and specifically uniform tension on extra ocular muscles during strabismus surgery. \*IRB approval from 1992 covered in letter from then IRB chair Dr. Judith Whitcomb, A...

What is the current status of trial NCT04353960?

This trial is currently recruiting. The enrollment target is 4,000 participants. The study started on 1992-09-01. Estimated completion is 2035-12-31.

What conditions does trial NCT04353960 study?

This clinical trial studies the following conditions: Bradycardia, Strabismus.

What interventions are being tested in trial NCT04353960?

The interventions under investigation include: electrocardiograph (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT04353960?

This trial is sponsored by Alaska Blind Child Discovery, which has 7 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04353960 being conducted?

This trial has 1 study location across Alaska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Bradycardia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.